King Cannabis on LATAM, EU and U$A "tremendous opportunities for us to grow white label, to do wholesale, we can ship directly from Canada into the Colombia market, with all our GMP certifications and our licenses, the opportunity for Europe is going to be tremendous. And don't be surprised if Germany becomes legalized over the next couple of years. When U.S. opens up for rec or medical, I think they're going to look at the companies that can bring a lot of the history and a lot of the data and financially be able to get going. I think as you come back and look at the different states in the U.S., they're going to want to deal with companies that really have a good history and have been able to build out companies and have quality and have regulatory, etc. So I think there is an opportunity for those legalization. Aphria will be right in line to get additional licenses. And if there is not, is there going to be an opportunity for us to acquire licenses with our history, so that's number one, and we're going to be swimming around to see where there is those opportunities.
Secondly is we're looking at opportunities in the U.S. to acquire companies that either have distribution, that have maybe a medical business or a consumer business when it does become legalized, where there's a conversion here or they have a distribution business, and that helps us to get into the U.S. market. And with 27 years of history in the consumer world in the U.S. market, myself, and some of my team members, we know the U.S. market quite well. So I want to take every bit of expertise that we have in the Canadian market and the international markets, both on rec and on medical and one day translate that into the opportunity in the U.S. market.